Cargando…

Guidelines on Vaccinations in Paediatric Haematology and Oncology Patients

Objective. Vaccinations are the most important tool to prevent infectious diseases. Chemotherapy-induced immune depression may impact the efficacy of vaccinations in children. Patients and Methods. A panel of experts of the supportive care working group of the Italian Association Paediatric Haematol...

Descripción completa

Detalles Bibliográficos
Autores principales: Cesaro, Simone, Giacchino, Mareva, Fioredda, Francesca, Barone, Angelica, Battisti, Laura, Bezzio, Stefania, Frenos, Stefano, De Santis, Raffaella, Livadiotti, Susanna, Marinello, Serena, Zanazzo, Andrea Giulio, Caselli, Désirée
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020520/
https://www.ncbi.nlm.nih.gov/pubmed/24868544
http://dx.doi.org/10.1155/2014/707691
_version_ 1782316080538058752
author Cesaro, Simone
Giacchino, Mareva
Fioredda, Francesca
Barone, Angelica
Battisti, Laura
Bezzio, Stefania
Frenos, Stefano
De Santis, Raffaella
Livadiotti, Susanna
Marinello, Serena
Zanazzo, Andrea Giulio
Caselli, Désirée
author_facet Cesaro, Simone
Giacchino, Mareva
Fioredda, Francesca
Barone, Angelica
Battisti, Laura
Bezzio, Stefania
Frenos, Stefano
De Santis, Raffaella
Livadiotti, Susanna
Marinello, Serena
Zanazzo, Andrea Giulio
Caselli, Désirée
author_sort Cesaro, Simone
collection PubMed
description Objective. Vaccinations are the most important tool to prevent infectious diseases. Chemotherapy-induced immune depression may impact the efficacy of vaccinations in children. Patients and Methods. A panel of experts of the supportive care working group of the Italian Association Paediatric Haematology Oncology (AIEOP) addressed this issue by guidelines on vaccinations in paediatric cancer patients. The literature published between 1980 and 2013 was reviewed. Results and Conclusion. During intensive chemotherapy, vaccination turned out to be effective for hepatitis A and B, whilst vaccinations with toxoid, protein subunits, or bacterial antigens should be postponed to the less intensive phases, to achieve an adequate immune response. Apart from varicella, the administration of live-attenuated-virus vaccines is not recommended during this phase. Family members should remain on recommended vaccination schedules, including toxoid, inactivated vaccine (also poliomyelitis), and live-attenuated vaccines (varicella, measles, mumps, and rubella). By the time of completion of chemotherapy, insufficient serum antibody levels for vaccine-preventable diseases have been reported, while immunological memory appears to be preserved. Once immunological recovery is completed, usually after 6 months, response to booster or vaccination is generally good and allows patients to be protected and also to contribute to herd immunity.
format Online
Article
Text
id pubmed-4020520
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-40205202014-05-27 Guidelines on Vaccinations in Paediatric Haematology and Oncology Patients Cesaro, Simone Giacchino, Mareva Fioredda, Francesca Barone, Angelica Battisti, Laura Bezzio, Stefania Frenos, Stefano De Santis, Raffaella Livadiotti, Susanna Marinello, Serena Zanazzo, Andrea Giulio Caselli, Désirée Biomed Res Int Review Article Objective. Vaccinations are the most important tool to prevent infectious diseases. Chemotherapy-induced immune depression may impact the efficacy of vaccinations in children. Patients and Methods. A panel of experts of the supportive care working group of the Italian Association Paediatric Haematology Oncology (AIEOP) addressed this issue by guidelines on vaccinations in paediatric cancer patients. The literature published between 1980 and 2013 was reviewed. Results and Conclusion. During intensive chemotherapy, vaccination turned out to be effective for hepatitis A and B, whilst vaccinations with toxoid, protein subunits, or bacterial antigens should be postponed to the less intensive phases, to achieve an adequate immune response. Apart from varicella, the administration of live-attenuated-virus vaccines is not recommended during this phase. Family members should remain on recommended vaccination schedules, including toxoid, inactivated vaccine (also poliomyelitis), and live-attenuated vaccines (varicella, measles, mumps, and rubella). By the time of completion of chemotherapy, insufficient serum antibody levels for vaccine-preventable diseases have been reported, while immunological memory appears to be preserved. Once immunological recovery is completed, usually after 6 months, response to booster or vaccination is generally good and allows patients to be protected and also to contribute to herd immunity. Hindawi Publishing Corporation 2014 2014-04-29 /pmc/articles/PMC4020520/ /pubmed/24868544 http://dx.doi.org/10.1155/2014/707691 Text en Copyright © 2014 Simone Cesaro et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Cesaro, Simone
Giacchino, Mareva
Fioredda, Francesca
Barone, Angelica
Battisti, Laura
Bezzio, Stefania
Frenos, Stefano
De Santis, Raffaella
Livadiotti, Susanna
Marinello, Serena
Zanazzo, Andrea Giulio
Caselli, Désirée
Guidelines on Vaccinations in Paediatric Haematology and Oncology Patients
title Guidelines on Vaccinations in Paediatric Haematology and Oncology Patients
title_full Guidelines on Vaccinations in Paediatric Haematology and Oncology Patients
title_fullStr Guidelines on Vaccinations in Paediatric Haematology and Oncology Patients
title_full_unstemmed Guidelines on Vaccinations in Paediatric Haematology and Oncology Patients
title_short Guidelines on Vaccinations in Paediatric Haematology and Oncology Patients
title_sort guidelines on vaccinations in paediatric haematology and oncology patients
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020520/
https://www.ncbi.nlm.nih.gov/pubmed/24868544
http://dx.doi.org/10.1155/2014/707691
work_keys_str_mv AT cesarosimone guidelinesonvaccinationsinpaediatrichaematologyandoncologypatients
AT giacchinomareva guidelinesonvaccinationsinpaediatrichaematologyandoncologypatients
AT fioreddafrancesca guidelinesonvaccinationsinpaediatrichaematologyandoncologypatients
AT baroneangelica guidelinesonvaccinationsinpaediatrichaematologyandoncologypatients
AT battistilaura guidelinesonvaccinationsinpaediatrichaematologyandoncologypatients
AT bezziostefania guidelinesonvaccinationsinpaediatrichaematologyandoncologypatients
AT frenosstefano guidelinesonvaccinationsinpaediatrichaematologyandoncologypatients
AT desantisraffaella guidelinesonvaccinationsinpaediatrichaematologyandoncologypatients
AT livadiottisusanna guidelinesonvaccinationsinpaediatrichaematologyandoncologypatients
AT marinelloserena guidelinesonvaccinationsinpaediatrichaematologyandoncologypatients
AT zanazzoandreagiulio guidelinesonvaccinationsinpaediatrichaematologyandoncologypatients
AT casellidesiree guidelinesonvaccinationsinpaediatrichaematologyandoncologypatients